Skip to main content
Search Button
United States Kobo store Gift Cards Help

Rakuten Kobo

Wishlist

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...


Showing 1 - 12 of 12 results for “e neil moore”
Skip side bar filters

  • Congestive Heart Failure

    Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania

    by J. Morganroth, E. Neil Moore ...
    Series series Medicine (R0)
    About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues ... Read more

    $215.99 USD

  • Silent Myocardial Ischemia

    Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania

    Edited by J. Morganroth, E. Neil Moore ...
    Series Book 88 - Developments in Cardiovascular Medicine
    Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina sufferers in the United states have frequent episodes of silent myocardial ischemia. Although it is not ... Read more

    $143.09 USD

  • Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

    Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

    Edited by J. Morganroth, E. Neil Moore ...
    Series Book 100 - Developments in Cardiovascular Medicine
    The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: ... Read more

    $188.09 USD

  • Cardiac Arrhythmias: New Therapeutic Drugs and Devices

    Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984

    Edited by J. Morganroth, E. Neil Moore ...
    Series series Medicine (R0)
    In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability of anyone model to define the probability of antiarrhythmic efficacy in man. It has therefore become ... Read more

    $143.99 USD

  • Interventions in the Acute Phase of Myocardial Infarction

    Edited by J. Morganroth, E. Neil Moore ...
    Series series Medicine (R0)
    In the 1980's a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is about a 20% chance of a North American male developing myocardial in farction before the age of 65. The ... Read more

    $89.09 USD

  • The Evaluation of New Antiarrhythmic Drugs

    Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: The Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, held at Philadelphia, Pennsylvania, October 8–9, 1980

    Edited by J. Morganroth, E. Neil Moore, L.S. Dreifus, E.L. Michelson ...
    Series series Medicine (R0)
    Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The sustained arrhythmias initiated in these models using programmed pacing presumably have the same ... Read more

    $49.49 USD

  • Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment

    Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982

    Edited by E. Neil Moore, J. Morganroth ...
    Series series Medicine (R0)
    In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three ... Read more

    $143.99 USD

People who read these also enjoyed

  • Mechanical Circulatory Support: Principles and Applications

    by Matthias Locke, David L. Joyce, Lyle D. Joyce ...
    An all-in-one guide to mechanical assist devices for the treatment of heart failureThis complete guide addresses all of the clinical scenarios encountered by the health care team during the pre-operative, intra-operative, and post-operative periods following device implantation. In addition, it outlines the specific attributes of various technologies that are currently utilized by clinicians, ... Read more

    $98.89 USD

  • Hypertension: Pre-Hypertension to Heart Failure, An Issue of Cardiology Clinics

    by Kenneth Jamerson, MD, James Brian Byrd, MD ...
    Series Book Volume 35-2 - The Clinics: Internal Medicine
    This issue of Cardiology Clinics, edited by Drs. Kenneth Jamerson and Brian Byrd will cover the current consensus on Hypertension, from Pre-Hypertension to Heart Failure. Topics covered in this issue include: genomic approaches to hypertension; drug and non-drug therapeutic approaches for pre-hypertension; air pollution and hypertension; social determinants of cardiovascular health; management of ... Read more

    $75.59 USD

  • Myocardial Failure

    International Symposium, Rottach-Egern/Tegernsee, Germany, June 17-19, 1976

    by H.-D. Bolte ...
    Series series Medicine (R0)
    More than 10 years have passed since the memorable symposium on "Myocardial Contractility," edited by R. D. Tanz, F. Kavaler and J. Roberts (New York and London, Academic Press, 1967). PathogeneSis of myocardial failure still involves many questions. The latest scien tific findings on fundamentals of myocardial contraction encouraged us to organize this international symposium held in Rottach ... Read more

    $89.09 USD

  • New Paradigms of Coronary Artery Disease

    Hibernation, Stunning, Ischemic Preconditioning

    Edited by G. Heusch, R. Schulz ...
    Detailed analyses of regional myocardial blood flow, function, metabolism and morphology in ischemic and reperfused myocardium have led to the identifi cation of important phenomena, i. e. , myocardial hibernation, myocardial stun ning and ischemic preconditioning. Both the hibernating and the stunned myocardium characterize viable though dysfunctional as distinguished from necrotic tissue. With ... Read more

    $89.09 USD

  • The Lancet: Cardiovascular Disease 2012

    Clinical Series

    by The Lancet ...
    This book, featuring content from the Aug 11, 2012, issue of The Lancet, has been released to coincide with the European Society of Cardiology (ESC) meeting in Munich, Germany, which is to be held on Aug 25–29, 2012. The Lancet is strongly supportive of cardiology as can be seen from the substantial relevant content in this compilation. In 2011, The Lancet published more papers in this specialty ... Read more

    Free